What you will find on this page
- What is Connected Care?
- How Connected Care supports patient care
Connected Care is a transformational approach to hearing care where patient data and insights seamlessly connect across different care settings – from the surgical suite to the clinic, and into a patient’s everyday life.
We know how important your patients, their progress and hearing outcomes are to you. We also understand that prioritising quality patient care as you face increasing demands on your time can be a challenge. Connected Care offers new tools that give you the flexibility to customise patient care, increase clinic efficiency and maximise your time - so you can focus on what matters most.
As the global leader in implantable hearing, with more than 650,000 devices implanted, our Connected Care solutions are built on extensive programming data and patient insight. By bringing together our evidence-based solutions and your expertise, Connected Care helps you optimise hearing outcomes for each patient at every stage of their hearing journey.
Supporting patient care
With Connected Care you can:
- stay connected to your patients and better monitor their performance in the clinic and the real world
- increase clinic efﬁciency, enabling you to provide quality, convenient care to an increasing patient base
- empower patients to manage their devices and hearing experience
This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.